Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulmatrix (PULM) EBITDA Margin (2016 - 2024)

Pulmatrix (PULM) has disclosed EBITDA Margin for 11 consecutive years, with 65066.67% as the latest value for Q4 2024.

  • Quarterly EBITDA Margin fell 6496562.0% to 65066.67% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 207100.0% through Sep 2025, down 20699969.0% year-over-year, with the annual reading at 125.07% for FY2024, 7690.0% up from the prior year.
  • EBITDA Margin hit 65066.67% in Q4 2024 for Pulmatrix, down from 725.96% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 12.69% in Q1 2024 to a low of 65066.67% in Q4 2024.
  • Historically, EBITDA Margin has averaged 3539.48% across 5 years, with a median of 262.83% in 2022.
  • Biggest five-year swings in EBITDA Margin: surged 63340bps in 2022 and later crashed -6496562bps in 2024.
  • Year by year, EBITDA Margin stood at 133.7% in 2020, then crashed by -563bps to 886.62% in 2021, then skyrocketed by 71bps to 253.22% in 2022, then soared by 60bps to 101.04% in 2023, then crashed by -64294bps to 65066.67% in 2024.
  • Business Quant data shows EBITDA Margin for PULM at 65066.67% in Q4 2024, 725.96% in Q3 2024, and 380.22% in Q2 2024.